General Infectious Disease News Articles

Infectious Dis.

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sohn HS et al. - Micafungin was a cost-effective prophylactic antifungal strategy by providing lower medical costs and longer life expectancy than fluconazole from the payer's perspective in a hypothetical cohort of Korean adults undergoing HSCT.

Today in Antimicrobials...keeping you current

Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09

Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals
Canadian Journal of Infectious Diseases, 12/15/09

Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid
International Journal of Infectious Diseases, 12/15/09